Gene Therapy in Ophthalmic diseases
Gene Therapy in Ophthalmic diseases Gene therapy has emerged as a groundbreaking approach in the treatment of various ophthalmic diseases, particularly those that are inherited or otherwise caused by specific genetic mutations. Here are some of the key aspects and recent advancements in gene therapy related to ophthalmology: 1. Inherited Retinal Diseases Inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis (LCA) are significant targets for gene therapy. These conditions often stem from mutations in specific genes that are crucial for retinal function. Luxturna (voretigene neparvovec) : This was the first FDA-approved gene therapy for an inherited eye disease, designed to treat LCA caused by RPE65 gene mutations. It involves delivering a normal copy of the RPE65 gene directly to retinal cells via an adeno-associated virus (AAV) vector. 2. Age-Related Macular Degeneration (AMD) While most AMD cases are not inherited, gen...